Literature DB >> 23257221

Pretreatment antiretroviral exposure from recreational use.

David J Grelotti1, Elizabeth F Closson, Matthew J Mimiaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23257221      PMCID： PMC4299817          DOI： 10.1016/S1473-3099(12)70294-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  A case of voluntary intoxication with efavirenz and lamivudine.

Authors:  Rémy T Boscacci; Thierry Buclin; Hansjakob Furrer; Christoph A Fux
Journal:  AIDS       Date:  2006-06-12       Impact factor: 4.177

2.  Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

Authors:  Raph L Hamers; Rob Schuurman; Kim C E Sigaloff; Carole L Wallis; Cissy Kityo; Margaret Siwale; Kishor Mandaliya; Prudence Ive; Mariette E Botes; Maureen Wellington; Akin Osibogun; Ferdinand W Wit; Michèle van Vugt; Wendy S Stevens; Tobias F Rinke de Wit
Journal:  Lancet Infect Dis       Date:  2011-10-27       Impact factor: 25.071

3.  Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

Authors:  R D Harrington; J A Woodward; T M Hooton; J R Horn
Journal:  Arch Intern Med       Date:  1999-10-11

4.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

5.  Over-the-counter and prescription medicine misuse in Cape Town--findings from specialist treatment centres.

Authors:  Bronwyn Myers; Nandi Siegfried; Charles D H Parry
Journal:  S Afr Med J       Date:  2003-05

6.  Patterns of substance use in South Africa: results from the South African Stress and Health study.

Authors:  Margaretha S van Heerden; Anna T Grimsrud; Soraya Seedat; Landon Myer; David R Williams; Dan J Stein
Journal:  S Afr Med J       Date:  2009-05

7.  HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.

Authors:  Christa Kasang; Samuel Kalluvya; Charles Majinge; August Stich; Jochen Bodem; Gilbert Kongola; Graeme B Jacobs; Mathias Mlewa; Miriam Mildner; Irina Hensel; Anne Horn; Wolfgang Preiser; Gert van Zyl; Hartwig Klinker; Eleni Koutsilieri; Axel Rethwilm; Carsten Scheller; Benedikt Weissbrich
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

8.  Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Authors:  Ravindra K Gupta; Michael R Jordan; Binta J Sultan; Andrew Hill; Daniel H J Davis; John Gregson; Anthony W Sawyer; Raph L Hamers; Nicaise Ndembi; Deenan Pillay; Silvia Bertagnolio
Journal:  Lancet       Date:  2012-07-23       Impact factor: 79.321
  8 in total
  17 in total

1.  Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

Authors:  Jessica M Fogel; Lei Wang; Teresa L Parsons; San-San Ou; Estelle Piwowar-Manning; Ying Chen; Victor O Mudhune; Mina C Hosseinipour; Johnstone Kumwenda; James G Hakim; Suwat Chariyalertsak; Ravindre Panchia; Ian Sanne; Nagalingeswaran Kumarasamy; Beatriz Grinsztejn; Joseph Makhema; Jose Pilotto; Breno R Santos; Kenneth H Mayer; Marybeth McCauley; Theresa Gamble; Namandjé N Bumpus; Craig W Hendrix; Myron S Cohen; Susan H Eshleman
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Whoonga: potential recreational use of HIV antiretroviral medication in South Africa.

Authors:  David J Grelotti; Elizabeth F Closson; Jennifer A Smit; Zonke Mabude; Lynn T Matthews; Steven A Safren; David R Bangsberg; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2014-03

3.  Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.

Authors:  Kerry A Thomson; Jessica E Haberer; Mark A Marzinke; Andrew Mujugira; Craig W Hendrix; Connie Celum; Patrick Ndase; Allan Ronald; David R Bangsberg; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

4.  Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.

Authors:  Iris Chen; Matthew B Connor; William Clarke; Mark A Marzinke; Vanessa Cummings; Autumn Breaud; Jessica M Fogel; Oliver Laeyendecker; Sheldon D Fields; Deborah Donnell; Sam Griffith; Hyman M Scott; Steven Shoptaw; Carlos del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

5.  Recreational ART use among individuals living with HIV/AIDS in South Africa: Examining longitudinal ART initiation and viral suppression.

Authors:  Jessica F Magidson; Hari S Iyer; Kristen S Regenauer; David J Grelotti; Janan J Dietrich; Ingrid Courtney; Gugu Tshabalala; Catherine Orrell; Glenda E Gray; David R Bangsberg; Ingrid T Katz
Journal:  Drug Alcohol Depend       Date:  2019-03-22       Impact factor: 4.492

6.  Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Authors:  Mark A Marzinke; William Clarke; Lei Wang; Vanessa Cummings; Ting-Yuan Liu; Estelle Piwowar-Manning; Autumn Breaud; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos del Rio; Manya Magnus; Sharon Mannheimer; Sheldon D Fields; Kenneth H Mayer; Darrell P Wheeler; Beryl A Koblin; Susan H Eshleman; Jessica M Fogel
Journal:  Clin Infect Dis       Date:  2013-10-02       Impact factor: 9.079

7.  Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment.

Authors:  Caroline Kuo; Danielle Giovenco; Teresa DeAtley; Jackie Hoare; Kristen Underhill; Millicent Atujuna; Catherine Mathews; Dan J Stein; Larry K Brown; Don Operario
Journal:  AIDS Behav       Date:  2020-09

8.  Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.

Authors:  Steven P Kurtz; Mance E Buttram; Hilary L Surratt
Journal:  AIDS Care       Date:  2013-09-16

9.  Trajectories of initiation for the heroin-based drug whoonga - qualitative evidence from South Africa.

Authors:  Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti
Journal:  Int J Drug Policy       Date:  2020-06-12

10.  Whoonga and the abuse and diversion of antiretrovirals in Soweto, South Africa.

Authors:  Kathryn Rough; Janan Dietrich; Thandekile Essien; David J Grelotti; David R Bansberg; Glenda Gray; Ingrid T Katz
Journal:  AIDS Behav       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.